Ironwood, Forest ship IBS drug
Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc. have released Linzess, a medication for irritable bowel syndrome (IBS), to U.S. pharmacies.
Supplier News
AstraZeneca: Crestor U.S. patent is upheld
AstraZeneca reported that the Court of Appeals for the Federal Circuit has upheld a decision of the U.S. District Court in Delaware that the substance patent protecting its cholesterol-lowering drug Crestor is "valid and enforceable.
SoloHealth kiosk sees sharp rise in consumer use
SoloHealth reported that its SoloHealth Station health and wellness kiosk has seen consumer engagement surge over 200% since late summer. The company said Thursday that to date nearly 5 million consumers have interacted with the health screening kiosk, up from 2.5 million in late August.
Elite announces supply pact for phentermine API
Elite Pharmaceuticals Inc. has shored up its supply of phentermine active ingredient for the next year. The company said Thursday that it has in place an agreement with the its sole supplier of the active pharmaceutical ingredient for its product lines that include phentermine HCl tablets (37.
Markwins wraps up Physicians Formula acquisition
Markwins International has completed its purchase of Physicians Formula Holdings Inc., a deal valued at about $75 million. Markwins said Wednesday that it has acquired all of the outstanding stock of Physicians Formula for $4.90 per share in cash.
Emerson Group names new partners
The Emerson Group has named Clark Tyndall, Sue Smith and Brian Schaefer as new partners. The consumer products consulting and services firm said Tuesday that Tyndall, Smith and Schaefer will join its Partner Group.
Nexafed decongestant thwarts illegal meth makers
Acura Pharmaceuticals Inc. has launched Nexafed, a nasal decongestant with a technology that disrupts the conversion of pseudoephedrine into the dangerous drug methamphetamine. Nexafed uses Acura’s Impede technology, which disrupts the extraction and conversion of pseudoephedrine to methamphetamine.
Pepsi inks landmark deal with Beyoncé
PepsiCo has entered wide-ranging global partnership singing superstar and model Beyoncé that the beverage giant said marks a new way that it teams with musical artists. Under the deal, Beyoncé will have her image on Pepsi can slated to debut in 2013.
Meda to purchase U.S. sleep aid product
Meda has signed an agreement to acquire MidNite, a over-the-counter sleeping aid. The Sweden-based company said Friday that the MidNite brand is well-established in the United States and holds a market-leading position in an expanding category. Marketed by Concepts In Health Inc.
Mars to debut limited-edition color blend of M&M’s
This month, Mars Chocolate North America plans to roll out a special edition of M&M’s with colors picked solely by fans.
Abreva, Olympian volleyballer spike myths about cold sores
Oral care brand Abreva is teaming up with Olympic volleyball gold medalist Misty May-Treanor in a campaign to dispell myths about cold sores.
AmerisourceBergen’s Howell appointed to new role
AmerisourceBergen Corp. has named Peyton Howell as a corporate senior vice president and as president of global sourcing and manufacturer relations. The pharmaceutical distributor said Wednesday that Howell assumes the new post immediately.
Ocean Global serves up natural remedy for vertigo
Ocean Global has introduced DiVertigo, an all-natural, over-the-counter remedy for vertigo symptoms.
AstraZeneca boosts pharmacy stock of Brilinta
AstraZeneca is kicking off a program with more than 26,000 national, regional and independent pharmacies to ramp up retail availability of Brilinta, an anticoagulant. The drug maker said Tuesday that the U.S.
Naterra’s Phase+ addresses diabetics’ skin problems
Naterra International Inc. has begun the national launch of Phase+, a skin care line designed to address the cosmetic effects that diabetes has on the skin.
Gorsky elected chairman of Johnson & Johnson
Seven months after becoming chief executive officer, Alex Gorsky has been elected as chairman of the board at Johnson & Johnson. J&J said Friday that current chairman Bill Weldon, Gorsky’s predecessor as CEO, is slated to step down on Dec. 28 and to retire early next year after a brief transitional